Parameter
|
Case
|
Day 0 (presentation)
|
Week 1 (days 1–7)
|
Week 2 (days 8–14)
|
Weeks 4–5 (days 22–35)
|
Week 10 (days 64–70)
|
Week 17 (days 113–119)
|
Weeks 38–39 (days 260–273)
|
Week 122 (days 848–854)
|
---|
Intraerythrocytic inclusions
|
1
|
positive
|
positive
|
positive
|
na
|
positive
|
positive
|
negative
|
na
|
2
|
positive
|
positive
|
positive
|
na
|
positive
|
negative
|
negative
|
na
|
3
|
positive
|
positive
|
positive
|
na
|
positive
|
negative
|
negative
|
na
|
4
|
negative
|
positive
|
positive
|
negative
|
na
|
na
|
negative
|
na
|
5
|
na
|
na
|
na
|
na
|
na
|
na
|
na
|
na
|
PCR for Cytauxzoon sp.a
|
1
|
na
|
positive
|
na
|
positive
|
positive
|
positive
|
positive
|
positive
|
2
|
positive
|
positive
|
na
|
positive
|
positive
|
positive
|
positive
|
positive
|
3
|
positive
|
positive
|
na
|
positive
|
positive
|
positive
|
positive
|
positive
|
4
|
negative
|
positive
|
na
|
positive
|
na
|
na
|
negative
|
na
|
5
|
na
|
na
|
na
|
positive
|
na
|
na
|
na
|
na
|
- Note: Cases 1–3 were treated with azithromycin and atovaquone from day 1 to 10 and from day 77 to 86. Case 4 was treated with azithromycin from day 6 to 21 and from day 260 to 270 and with atovaquone from day 11 to 21
- Abbreviation: na not applicable
- aScreened by real-time PCR and confirmed by conventional PCR and sequencing